The in vivo binding of D2 receptor ligands can be affected by agents that alter the concentration of endogenous dopamine. To define a more explicit relation between dopa mine and D2 receptor binding, the conventional compartment model for reversible ligands has been extended to account for a time-varying dopamine pulse. This model was tested with e tClraclopride positron emission tomography and dopamine microdialysis data that were acquired simultaneously in rhesus monkeys. The microdialysis data were incorporated into the model assuming a proportional relation to synaptic dopamine. Positron emission tomography studies used a bolus-plus infusion tracer delivery with amphetamine given at 40 minutes to induce dopamine release. The extended model described the Abbreviations used: Blr, bolus plus infusion; PET. positron emission tomography; TAC, time-activity curve. 932 entire striatal time-activity curve, including the decrease in radioactivity concentration after an amphetamine-induced do pamine pulse. Based on these results, simulation studies were performed using the extended model. The simulation studies showed that the percent decrease in specific binding after am phetamine measured with the bolus-plus-infusion protocol cor relates well with the integral of the postamphetamine dopamine pulse. This suggests that changes in specific binding observed in studies in humans can be interpreted as being linearly pro portional to the integral of the amphetamine-induced dopamine pulse. Key Words: Raclopride-Positron emission tomogra phy-Microdialysis-Compartmental models-D2 receptors.
Positron emission tomography (PET) and single photon emission computer tomography studies demon strate that administration of pharmacologic agents known to alter synaptic dopamine can affect the binding of D2 receptor radio ligands. It has been shown that sub stances known to increase synaptic dopamine such as amphetamine (Dewey et al., 1991; Innis et al., 1992) , methylphenidate (Volkow et al., 1994) , and tetrabena zine (Dewey et al., 1993) lead to a decrease in D2 ligand binding. Alternatively, stimulation of GABAergic (Dewey et al., 1992) or serotonergic neurons (Dewey et al., 1995) , both of which inhibit dopamine release, leads to increased D2 binding. In addition, pretreatment with reserpine, which depletes dopamine stores, greatly re duces the amphetamine-induced washout of the single photon emission computer tomography D2 ligand [ 1 2 3 IJiodobenzamide (Innis et al., 1992) . Furthermore, it has been shown by analysis of PET studies in primate and microdialysis studies in rat that an induced change in D2 ligand binding corresponds to an opposing change in dopamine level (Dewey et al., 1995) . These studies dem onstrate that D2 tracers can be used to indirectly observe changes in dopamine. However, this effect has not been described quantitatively; that is, a measured change in specific binding has not been related mathematically to an induced change in dopamine. Understanding this re lation would lead to better interpretation of dopamine competition studies in humans.
This report develops a mathematical model that de scribes the relation between tissue dopamine concentra tion and the binding of [ l l C]rac1opride. Data used for developing and testing the model came from combined PET and in vivo microdialysis studies in rhesus monkey that provided simultaneous measurement of [ I I C]rac1o pride and striatal dopamine (Breier et al., 1997) . To bet ter observe changes in tracer binding within a single study, bolus-plus-infusion (BII) tracer delivery (Carson et al., 1993a) was used to obtain a near constant level of [ II CJrac1opride in plasma and cerebral tissues. For each study, 40 minutes were allowed for the tracer to reach a stable level, at which time amphetamine was adminis tered to induce dopamine release. To describe the [llC] raclopride striatal time-activity curves (TAC), a two-tissue compartment model (Farde et aI., 1989) was extended to include the effects of dopamine using the measured microdialysis data. Using the extended model, simulations were performed to determine what feature of the induced dopamine pulse most strongly influences the PET signal. Further simulations were performed to in vestigate the effect of an amphetamine-induced blood flow change. THEORY [llC]raclopride is a reversible D2 antagonist with ki netics that can be described by a two-tissue compartment model (Farde et aI., 1989) . This section defines the ex tended model, which includes the effects of dopamine competition. The compartmental diagram of the model is shown in Fig. 1 , and the terminology is defined in Ta ble 1.
The conventional model for e I CJraclopride includes compartments for free (Cj) and specifically bound (Cb) tracer in tissue. The plasma-tissue exchange constants across the blood-brain barrier are K] and k2' and V e is the free volume of distribution (K/k2). The exchange be tween free and bound tracer is described by the binding rate k3 and the dissociation rate k4. The general form of the model differential equation is dCj Tt =KICp-(k2+k3)Cj+k4Cb
The binding rate is proportional to the free receptor con centration, (2) where kon is the bimolecular association rate constant for raclopride, and B free is the free receptor concentration. The total D2 receptor concentration Bmax is equal to the sum of bound raclopride, bound dopamine (Db)' and free receptor. The free receptor pool can thus be expressed as fo llows: (3) where SA is specific activity of [ 1 1 C]raclopride.
For high-specific activity studies, the receptor occu pancy of raclopride is negligible. Therefore, the free re ceptor concentration and the binding rate of raclopride are assumed to be constant. However, in these experi- ments, amphetamine causes both the free and bound do pamine concentrations to change; therefore, the free re ceptor concentration and the binding rate are time dependent. To account for the time-dependent binding rate, dopamine must be included in the model. We extend the conventional model by including addi tional compartments for free (Dj) and bound (Db) dopa mine. We ignore the binding of amphetamine to D2 re ceptors, which has been found to be negligible (Innis et aI., 1992) . The following assumptions regarding dopa mine D2 receptor binding were made: (l) dopamine re ceptor binding kinetics are sufficiently fast that bound dopamine is always in equilibrium with free synaptic dopamine, regardless of how rapidly free dopamine changes; thus, we do not add an additional differential equation to account for the binding of dopamine; and (2) high-and low-affinity binding sites for dopamine are not included; that is, dopamine is assumed to bind to D2 receptors with a single affinity. The effects of violations of these assumptions are presented in the discussion. With these assumptions, an equilibrium equation can be derived to relate free and bound dopamine, where KgA = J!;;!I!;;;, the equilibrium dissociation con stant for dopamine. In the absence of dopamine, Eq. 5 reduces to the conventional expression for the binding rate.
To apply the model, the ratio D f (t)/KgA in Eq. 5 must be related to the microdialysis data. We assume that the microdialysis dopamine concentration curve DP(t) is pro portional to the free dopamine concentration, that is,
In Eq. 6, a is a constant scale factor. We define a new parameter K!fy as follows:
When a is equal to 1, which corresponds to perfect mea surement of Df(t), then Ki> equals KgA . In these studies, J Cereb Blood Flow Metah, Vol. 17, No. 9, 1997 DP(t) is expected to underestimate Dit) (see Discus sion), i.e. a is less than 1, therefore, Ki> underestimates K D A D '
Upon substitution of Eqs. 5-7, the model equations (Eq. 1) can be expressed in terms of the microdialysis data DP(t) as follows:
There is no analytical solution to Eqs. 8 and 9 in the presence of an arbitrary time-varying dopamine concen tration; therefore, we used a fourth-order Runge-Kutta routine to solve the differential equations. The final tis sue model also included a term for intravascular radio activity, VhC;OT(t), where Vh is the blood volume and C;OT(t) is the total radioactivity concentration in blood.
METHODS

Animal studies
A complete description of the PET methodology used here is given by Carson et al. (1997) . Adult male rhesus monkeys (n = 3, 7 to 11 kg) were initially sedated with ketamine (10 mg!k.g intramuscularly) then anesthetized for the remainder of the study with isoflurane (1 % to 2%, to effect). Each animal was studied twice on the same day with approximately 3 hours separating the start of each study. Bolus-plus-infusion delivery of C IC]raciopride was used with a specific activity of 161 to 710 mCi/fLmol and injected dose of 2.0 to 6.0 mCi. The bolus volume was equal to 60 minutes of constant infusion; therefore, 40% of the total volume was delivered as a bolus for a 90minute study. The bolus volume was given over 1 minute.
Amphetamine was given as an intravenous bolus, usually at 40 minutes, with doses of 0.2 mg!k.g (study 1) and 0.4 mg/kg (study 2), respectively.
The PET studies were acquired using a Scanditronix PC2048-15B scanner (Uppsala, Sweden), which acquires 15 slices separated by 6.5 mm with reconstructed resolution of 6 to 7 mm full width at half maximum. A stereotactic head holder was used that positioned the head so as to obtain coronal slices.
Scan frames acquired were 6 x 30 seconds, 3 x 60 seconds, 2
x 120 seconds, 4 x 300 seconds, 8 x 150 seconds, and 8 x 300 seconds for a total study duration of 90 minutes. Arterial blood samples (0.5 to 1.0 mL) were collected throughout the study, and plasma was counted on a sodium iodide gamma counter calibrated so that counts per minute were converted to nano-curies per cubic centimeter. Blood samples collected at 5, 12, 25, 40, 60, and 90 minutes were analyzed for radioactive me tabolites (de Bartolomeis, 1996) . The unmetabolized fractions were fit to a model (Carson et aI., 1997) based on the method of Huang et al. (1991) to estimate the continuous plasma ra clopride time course.
Irregular regions of interest were drawn on three adjacent slices for both the left and right striatum, and on two adjacent slices for the cerebellum. Regions of interest were applied to all scan frames to generate T Ae. Final striatum and cerebellum TAC were derived from an area-weighted mean of the indi vidual TAe. Variance in the TAC was estimated (Carson et aI., 1993b) and provided weights for the model fits.
Microdialysis
Rhesus monkeys were prepared for in vivo microdialysis at least 3 months before PET scanning, as previously described . The surgical procedure involved a small cranial opening and stereotactic positioning of probe guide holders that were then fixed to the skull using bone cement. Each guide holder features a 4 x 15 array of holes « I mm diameter, 1 mm center-to-center distance) that was posi tioned over an area (6 to 8 mm x 15 to 20 mm) of removed skull through which dialysis probes could be inserted. To de termine which holes were most accurately aligned with the left and right caudate, vitamin E-filled silica barrels were placed through individual guide holes, but not into the brain, during magnetic resonance scanning. analyzed for dopamine content using high-performance liquid chromatography with electrochemical detection (Saunders et aI., 1994) . External dopamine standards (10-8 mollL) also were analyzed (n = 3, for each study) to generate a calibration factor that was used to convert the high-performance liquid chroma tography measurements to units of dopamine concentration (nmollL). Because the microdialysis samples were collected over 10minute intervals, the transient peak of the dopamine pulse was not adequately characterized by the data. To derive a continu ous curve DI1(t) from the data, the pulse was modeled as a monoexponential curve (Fig. 2) . The microdialysis data were fit to a model with five parameters: the initial baseline B1, the pulse height H, the clearance rate of the pulse R, the start time of the dopamine pulse �t, and the postamphetamine baseline B2, that is,
Utilization of microdialysis data
B 1 is the endogenous dopamine level in the absence of a stimu lus and provides a reference to evaluate the size of the pulse. In measurements taken more than 2 hours after amphetamine, the dopamine concentration did not return to the initial baseline, so the curve was modeled with a second baseline (B2). For the second study of each study pair, B2, was set equal to B] be cause there were insufficient postamphetamine data to reliably detect a change in baseline. Since each dialysate sample is an integral over 10 minutes, these data were fit to the integral of the model curve (Eq. 10). This ensured that the fitted curve would conserve the dopamine content measured by microdi alysis. For use in modeling the PET data, the fitted curve DI1(t) was shifted in time so that the dopamine pulse began at the time of amphetamine delivery, typically 40 minutes. Shifting DI1(t)
to begin 1 minute after amphetamine delivery produced little effect on the modeling results.
The microdialysis data underestimate the dopamine concen tration in vivo and ideally should be corrected by the in vivo recovery, that is, the ratio of the concentration of dopamine in the collected dialysate to the tissue concentration in vivo. This value is difficult to measure, however, so to approximate this correction, the microdialysis data were corrected by the in vitro recovery. To measure the in vitro recovery, the dialysis probe is placed in a stirred dopamine solution with a known concen tration. The in vitro recovery equals the ratio of the dopamine concentration in the collected dialysate to the known concen tration and will be greater than the in vivo recovery (see Dis cussion). The probes used in these experiments have a mea sured in vitro recovery of 30% to 40%. Here, the microdialysis data DI1(t) were scaled assuming a fixed in vitro recovery of 30%. Since the microdialysis data enter the model equations (Eqs. 8 and 9) as the ratio DI1(t)/K�, errors in estimating the in vivo recovery will produce matching errors in K�, with no change in the modeled tissue concentration curve. 
Tracer kinetic modeling
The free volume of distribution for the striatum V was set equal to V�, and the remaining five parameters Kj, Bm ax , Kjy, ko ff Vb ) were estimated from the striatal TAC.
Two studies were performed in each animal on a single day.
If there were no physiologic changes between studies, it would ideally be possible to model the data from both studies with a single set of floated parameters. This was tested in combined fits using the five-parameter model. For the two studies in each animal, Ve for each study was fixed to its corresponding V�, and Kj, Bmax' Kjy, k,�tt and Vb were estimated from striatal TAC of both studies simultaneously. To test if this combined fit could be improved with an additional parameter, the estimation pro cedure was repeated, allowing each study to have independent Kj values (i.e., a six-parameter fit).
Simulation studies
The study design used here-B/I delivery of e IClraclopride with amphetamine displacement-has been used to investigate the response to dopamine challenge in schizophrenic patients (Breier et aI., 1997) . This BII paradigm allows changes in spe cific binding to be determined within a single study without blood sampling (Carson et aI., 1997) . Through simulations, we applied the extended model to char acterize the relation between changes in specific binding mea sured in this manner and the underlying dopamine pulse. In particular, the dopamine pulse (Fig. 2) is characterized by its 
RESULTS
Microdialysis
For five of six amphetamine injections, the microdi alysis data were well described by the exponential model (Fig. 2) . In one study (with 0.2 mg/kg of amphetamine), the dopamine pulse had a poorly defined peak and was modeled as a polynomial curve. Based on these fitted curves, baseline dopamine was 17 ± 4 nmollL and 43 ± 14 nmollL before 0.2 mg/kg and 0.4 mg/kg of amphet amine, respectively. The estimate of baseline dopamine is consistent with a previously reported value of 31 nmol/L in rhesus monkey (Moghaddam et aI., 1993) . In the three animals, baseline dopamine measured before the 0.4 mg/kg study was 92%, 267%, and 108% larger than baseline dopamine measured before the 0.2 mg/kg study, possibly because of residual amphetamine effects. Dopamine pulses described by an exponential curve had a peak height of 489 ± 302 nmollL and a clearance rate of 0.06 ± 0.04 min-1 (halftime 14 ± 6 min). To compare the magnitude of dopamine release for different amphet amine doses, the average dopamine concentration was computed over the first 40 minutes after amphetamine, then expressed as a percent of the baseline dopamine concentration in the first study of each pair. For the three animals, dopamine increased by 620%, 1100%, and 96%, respectively, over baseline after 0.2 mg/kg of am phetamine. After 0.4 mg/kg of amphetamine, dopamine increased 1600%, 2500%, and 260%, respectively. Do pamine release after 0.4 mg/kg of amphetamine more than doubled over that after 0.2 mg/kg of amphetamine.
PET Data and modeling Figure 3 shows typical T AC data for striatum and cerebellum with model fits. Radioactivity in cerebral tis sues became nearly constant by 20 to 30 minutes by using a B/I protocol. After amphetamine, activity cleared from the striatum with no change in cerebellum. There was no apparent late increase in striatal activity within the 50-minute period postamphetamine.
The striatum data were fit to the six-and five parameter model, and a typical fitted curve for the five parameter model is shown in Fig. 3 . Parameter values are shown in Table 2 . The values obtained using both models were similar; however, the five-parameter model, with
Ve fixed from a cerebellar fit, gave smaller standard er rors for all parameters, particularly Bmax ' In four of six studies, the five-parameter model had a lower Akaike information criterion (Akaike, 1976) than the six parameter model. Therefore, we chose the five parameter model for further testing and performance of simulations.
The new parameter KiJ was determined in the five parameter fit to be 424 nmol/L. KiJ had a large intera nimal coefficient of variation of 69%, which could be because of its dependency on the efficiency of microdi alysis sampling (Eq. 7). Among other factors, the micro dialysis efficiency depends on in vivo recovery and probe positioning witnin the tissue, and thus will be different in studies with different probes and different animals. How ever, we performed paired studies in each animal with dialysis probes that remained in the same position throughout both studies. If there were no significant physiologic changes between the studies, then the pa rameter values should be the same for both studies. First, the cerebellum time-activity curve (TAG) (&) was fit to a two compartment, five-parameter model, and the volume of dis tribution V� was computed from the fitted model parameters (Eq. 11). The free volume of distribution in striatum Ve was set equal to V�, and five parameters were estimated to model the striatum TAG (.). This model described the break in the striatal curve after amphetamine (0.4 mg/kg at 40 minutes) and the prolonged depression of ["G)raclopride concentration. AMP, amphetamine. Therefore, we attempted combined fits to each pair of studies using the five-parameter model with a single set of floated parameters. In two of three animals, a single set of five floated parameters (K" Bmw' KiJ, ko iJi Vb) was sufficient to describe each pair of striatal T AC. Results for the third animal are shown in Fig. 4 . Here, the com bined fit was statistically improved (F test, P < .001) by using a six-parameter model that allowed both studies to have their own K, (K�, K7, Bmax, KIj), k off Vb)' In this fit, KJ and K7 were 0.146 and 0.117 mLimin/mL, respec tively. The success of the combined fits gives support to the adequacy of the model and the reliability of the pa rameters. 
Simulation studies
In Fig. 5 , simulated values of the percent reduction in specific binding LlSB (calculated from preamphetamine and postamphetamine radioactivity levels) are plotted versus three features of the dopamine pulse: pulse height (5A), clearance rate (5B), and integral (5C). It is found that LlSB does correlate with both the pulse height (r = 0.63) and the clearance rate (r = 0.69) (plots A and B), but there is considerable scatter. For example, in Fig. 5A , at a given d�pamine pulse height there is considerable variation in LlSB, with the largest LlSB value correspond ing to the smallest dopamine clearance ra,te. Clearly, the best correlation (r = 0.99) is found between LlSB and the integral of the dopamine pulse (Fig. 5C ). This sug gests that changes in specific binding measured in patient studies can be interpreted as linearly proportional to the integral of the dopamine pulse. Notice that K'fy is a scale factor for the dopamine pulse (Eq. 8), so that LlSB also is inversely proportional to K'fy.
Simulations of changes in blood flow showed a minor effect on specific binding changes. Adding a 25% step increase (decrease) in K, and k2 at the time of amphet amine administration altered LlSB by +5.5% (-7.2%). If blood flow exponentially returns to the initial flow rate, a smaller change in LlSB is observed.
DISCUSSION
We have extended the conventional compartment model for e I C]raclopride (Farde et aI., 1989) to include The parameter K'fy is linearly proportional to KgA , the dissociation constant for dopamine (Eq. 7), and thus should provide meaningful information about dopamine.
However, the value of K'fy depends on the accuracy of the microdialysis data as well as the characteristics of dopa mine physiology. We must carefully consider these is sues to understand what these experiments reveal about endogenous dopamine.
Microdialysis measurements
Extracellular dopamine measured with microdialysis
was used in these studies to estimate D f (t), the concen tration of dopamine in the vicinity of D2 receptor sites. Since there are both synaptic and extrasynaptic D2 re ceptor sites (Levey et aI., 1993; Sesack et aI., 1994; Yung et aI., 1995) , it is not clear if sampling from the extra cellular space provides a good measure of D f (t). In par ticular, we need to consider the relation between synaptic and extrasynaptic dopamine. Garris et al. (1994) suggests that dopamine uptake by the presynaptic transporter could produce a dopamine concentration gradient be- :.c;
.!l =5 8-., tween the synapse and extracellular fluid. However, based on a model of the efflux of dopamine from the synapse, they predicted that extracellular dopamine rap idly equilibrates with synaptic dopamine. Thus, even if there is a concentration gradient, it is reasonable to as sume that the concentrations of synaptic and extracellu lar dopamine are linearly proportional. Thus, we ap proximated the microdialysis data D!l(t) as being linearly proportional to Dj(t).
To accurat�ly estimate the extracellular dopamine concentration, the microdialysis data D !let) should be corrected for the in vivo recovery. To obtain an approxi mate estimate, D !l(t) was scaled by the in vitro recovery (see Methods). However, the in vivo recovery is less than the in vitro recovery, because the in vivo recovery is affected by tissue clearance mechanisms such as reup take and metabolism (Bungay et aI., 1990; Morrison et aI., 1991) . Therefore, even after scaling by the in vitro recovery, D !let) underestimates extracellular dopamine and K'fy underestimates Kg A .
An additional concern is that the in vivo recovery may not be constant throughout an experiment. In particular, amphetamine has been found to reduce the in vivo re covery of dopamine by up to 37% (Olson and Justice, 1993) , perhaps because of inhibition of the presynaptic dopamine transporter. Cocaine also has been found to lower the in VIVO recovery of dopamine (Smith and Jus tice, 1994) . The in vivo recovery depends on the rate that the surrounding tissue replenishes molecules that have been depleted by the dialysis probe. Molecules with a fast turnover rate are replaced more quickly than mol ecules with a slow turnover rate. Therefore, faster turn over corresponds to higher in vivo recovery (Bungay et aI., 1990; Morrison et aI., 199 1) . Blocking presynaptic uptake slows dopamine turnover and reduces in vivo re covery. As a consequence, the micro dialysis measure ment before amphetamine may have a higher in vivo recovery compared with the postamphetamine measure ment, which would result in an underestimation of the size of the do p amine pulse relative to baseline dopamine.
This would violate the assumption that D!l(t) and D ft) are linearly proportional (Eq. 6). To test the effect of violating this assumption, we simulated a change in the in vivo recovery and determined its effect on the fitted parameter values. For this simulation, a noise-free TAC from the five-parameter model fit was used as data, and fit to the model with a modified dopamine pulse. A 33% decrease in postamphetamine in vivo recovery (which is mathematically equivalent to a 50% increase in the pos tamphetamine dopamine pulse), produced a 51 % in crease in K'fy, with less than 2% changes in the other parameters. In contrast, a 33% increase in the pre am phetamine recovery caused K'fy to increase by only 5%, and no other parameter changed by more than 2%. This demonstrates that the estimated K'fy value is most sensi-tive to the in vivo recovery during the postamphetamine phase.
Even if we could accurately correct for in vivo recov ery, quantification of the dopamine pulse still may be problematic. Consider that after 0.4 mg/kg of amphet amine, the peak dopamine concentration in the three animals was 74, 672, and 839 nmol!L, respectively. This large range most likely results from differences in probe positioning, that is, a larger dopamine signal may indicate that the dialysis probe was more optimally lo cated among dopamine releasing sites during the experi ment.
Model assumptions
Dopamine binding kinetics. The compartmental model (Fig. 1) shows the association and dissociation of dopamine to the receptor. To simplify the model, we assumed that dopamine binding is in rapid equilibrium (i.e., /!,;; is infinitely fast), which allowed bound dopa mine Db(t) to be expressed explicitly in terms of Kg A and Dj(t). However, it is not clear that dopamine binding remains in secular equilibrium during the transient do pamine pulse induced by amphetamine. Based on a value of karl for neurotransmitter receptors of 0.06 nmol/L-J min-I and a lower bound for Kg A of 5 nmollL (high affinity), Logan et al. (199 1) estimated k�; to be as low as 0.3 min-I . To test the effect of a finite value of k�;, the differential equation for dopamine binding was added to the model. Using typical microdialysis data and pa rameters, noise-free striatal TAC were generated with different k!;; values and k!;;; equal to 0.06 nmol/L-I min-I . These TAC were compared with the TAC gener ated with the original extended model. For k� equal to 0.3 min-I , there was less than a 2% difference in radio activity concentration at all time points, with the greatest difference found within the first 10 minutes after am phetamine. Fitting this T AC to the five-parameter model yielded less than 4% changes in the fitted parameter values. For k�; values greater than 0.3 min-I, the dif ferences were smaller. Thus, the assumption that dopa mine binding is in continuous secular equilibrium should not affect the accuracy of the model.
Relation between kon and Bmax-Because of the large doses of [l l C]raclopride used in these studies, we in cluded the nonnegligible receptor occupancy of raclo pride in the model. This required separation of the terms karl and Bma X ' To constrain the model, kan was fixed to 0.0 15 min-I, which is at the upper range of values mea sured in humans (Farde et aI., 1989) . To determine how a smaller value of kan would affect the fitted parameter values, noise-free striatal TAC were generated with kan equal to 0.0 15 min-I, then fit to the model with kan set to 0.0075. In these fits, Bmax, K'fy, and ka ff increased by 92%, 14%, and 8%, respectively. If receptor occupancy by raclopride was negligible, then kan and Bmax would be perfectly correlated, so that changes in kon would pro duce matching changes in Bmax (so konBmax remains con stant) and K'i> and ko J f would be unaffected. The weak dependence of K'i> and ko J f on the assumed value of kon is caused by the dependence of kit) on the receptor occu pancy of raclopride (Eq. 5).
Multiple-affinity states. Although O2 receptors have high-and low-affinity states for agonist binding (Sibley et aI., 1982) , we assumed that dopamine binds with a single affini�y. To investigate the effects of violating this assumption, we performed simulations where the O2 re ceptors have two affinity states (or equivalently where raclopride binds to two receptor SUbtypes having differ ent affinities). Let j� be the fraction of receptors in the low-affinity state Kt, with the remaining fraction (1 -fL) in the high-affinity state Kl£. We assumed that the frac tionf L remained constant during these studies. Assuming that dopamine binding is in equilibrium at both affinities, and that raclopride binds at a single affinity, two equi librium equations for dopamine binding, analogous to Eq. 4, can be written for each affinity state, and the raclopride binding rate becomes Equation 12 replaces Eq. 5 and was used to derive differential equations analogous to Eqs. 8 and 9.
Simulations were performed to determine how the presence of two affinity states affects parameter values. A wide range of values have been determined experi mentally for Kg (2.8 to 474 nmollL) and Kt (1705 to 2490 nmollL) (Gingrich and Caron, 1993) , and for the fraction of receptors in each state (j� = 10% to 77%) (Sibley et aI., 1982; Richfield et aI., 1986; Ross, 1991) .
Initial simulations were performed with a range of f L values and a 10: I affinity ratio Kt/Kl£ using Ko values that yielded T AC similar to those obtained in these stud ies. Noise-free TAC generated using the two-affinity model were fit to the original five-parameter model. As f L varied from 0 to 1, the estimated K'i> value varied between Kl£ and Kt. Bmax was slightly underestimated, more so for low f L values. A second set of simulations was performed with a 100: 1 affinity ratio where Kl£ was reduced; therefore, baseline dopamine occupied a signifi cant fraction of the high-affinity sites. Compared with using a 10: 1 affinity ratio, the estimated value of K'i> was much closer to Kt. In addition, the estimate of Bmax was close to f L Bmax, that is, the fraction of receptors in the low-affinity state. Apparently, as Kl£ gets increasingly small (leading to greater baseline dopamine occupancy), J Cereb Blood Flow Metab, Vol. 17, No.9, 1997 the high-affinity sites become less accessible to raclo pride, which leads to an underestimate of Bmax. Since competition then would take place primarily at low affinity sites, the estimated value of K'fy becomes closer to Kt. Thus, in the presence of two affinity states for dopamine, the estimated value of K'i> lies between Kl£ and Kt.
Measurement of the input function. The model as sumes that the input function is measured perfectly. However, with metabolite measurements at only a few sample times, the limited statistics of the late data will introduce nontrivial errors in the input function that can affect the quality of model fits. We assessed the sensi tivity of the fitted parameters to errors in the metabolite correction by simulations. In fits to the extended model, a 10% bias in the input function (beyond 60 minutes) could lead to errors in the estimate of K'i> of 40% or more, with less than 10% errors in the remaining param eters. Underestimating the late input function caused the model to overestimate K'fy because, in this case, some of the postamphetamine drop in the tissue curve ( Fig. 3 ) was attributed to a drop in the input function level. Thus,
K'fy is sensitive to the accuracy of the metabolite correc tion, and this likely contributes to the large variability observed in K'i>. However, the ability to perform com bined fits of paired studies with a single set of parameter values suggests sufficient reliability in the measurement of the input functions in these studies.
Inferences from the model
Interpretation of aSB. With the B/l protocol, the percent reduction in specific binding (L�SB) can be mea sured directly from the preamphetamine and postamphet amine tissue concentration values. The simulations showed that L\SB is linearly proportional to the integral of the dopamine pulse. Notice that simulations with bi exponential pulses also showed strong correlation be tween the pulse integral and L\SB. The effect of an in duced blood flow change is minor. Thus, for multiple studies in a particular subject, assuming there are no changes in dopamine physiology, the relative changes in specific binding should predict the magnitude (integral) of the amphetamine-induced dopamine pulse. However, caution must be used in extending this result to the com parison of studies in different subjects or under different physiologic conditions. Differences in L\SB also could be attributed to different K'i> values; that is, an increase in ASB could result from an increase in the dopamine pulse, or a decrease in K'fy, or a combination of the two. Dif ferences in K� values between patient groups could oc cur by having different proportions of receptors in high and low-affinity states.
Further simulations were performed to test if the val ues of k Off Bmax, or the baseline dopamine level also could affect ASB. A 20% increase (decrease) in k OjJ changed ASB by +6.6% (-12.1 %). A faster k OjJ causes raclopride to clear more rapidly in response to a dopa mine pulse, ana therefore leads to a greater change in specific binding. A ±20% change in Bmax had a negli gible effect on ASB; thus, dopamine displaces a similar fraction of specifically bound raclopride, regardless of changes in Bmax. The baseline dopamine level also had little effect on ASB unless some of the receptors were in the high-affinity state. In the case of two affinity states with KtlKZ = 100 and f L = 50%, a 20% decrease (increase) in baseline dopamine changed the control ASB by +8.1 % (-6.4%). As baseline dopamine increases and occupies more of the high-affinity sites, the subsequent dopamine pulse occupies fewer receptors (and displaces less raclopride) because most of the remaining sites are in the low-affinity state. Thus, the model predicts that the dopamine pulse and K� are the primary determinants of ASB, with lesser effects attributed to koff and baseline dopamine. D2 receptor occupancy. Based on the model param eters and the baseline microdialysis data (B 1 )' it is theo retically possible to calculate the D2 receptor occupancy. Specifically, inserting Eqs. 6, 7, and 10 into Eq. 4, the occupancy is predicted to be B/(K� + B 1 ). Baseline dopamine receptor occupancy in these studies was only 3% to 15%, because baseline dopamine (17 nmol/L) was small compared with K� (424 nmollL). This estimate of the receptor occupancy appears to be inconsistent with the results of Dewey et al. (1995) and Laruelle et al. (1997) , which showed that dopamine depletion can in crease D2 ligand specific binding by more than 30%. Such an increase would require at least a 25% occupancy of D2 receptors by baseline dopamine (Laruelle et aI., 1997) . A possible explanation is that the estimate of K� from this model reflects a combination of high and low affinities. For example, if 50% of receptors were in the high-affinity state and baseline dopamine is comparable with K�, then about 50% of the high-affinity receptors and about 25% of all receptors would be occupied by baseline dopamine.
The peak occupancy of D2 receptors by dopamine af ter amphetamine can be similarly estimated based on the peak of the dopamine curve (B2 + H; Eq. 10), and is given by (B2 + H)/(K'fy + B2 + H). To estimate the peak occupancy, K� values from the combined fits were used. The predicted peak occupancy was 52 ± 19% and 62 ± 12% for 0.2 mg/kg and 0.4 mg/kg of amphetamine, re-spectively. Notice that the large increase in dopamine produced by 0.4 mg/kg of amphetamine, in comparison with 0.2 mg/kg, produced only a moderate increase in satu ration because of the nonlinearity of receptor binding.
Return of radioactivity to preamphetamine level. In these studies, an amphetamine-induced dopamine pulse displaced e l C]raclopride from the receptors. Because of the continuous infusion, it would be expected that raclo pride will reoccupy receptors as dopamine clears. How ever, despite the rapid clearance of dopamine (Fig. 2) , the striatal radioactivity concentration did not rapidly return to its preamphetamine level, but rather, it re mained depressed throughout postamphetamine data ac quisition. This demonstrates that the response to an am phetamine-induced dopamine pulse is driven primarily by the tissue kinetics of raclopride (k2, ko11' ko ff ), which are not fast enough to follow transient changes in dopamine.
To estimate when the radioactivity concentration after amphetamine would approach the pre amphetamine equi librium value, T AC were simulated using an input func tion that remained constant beyond 40 minutes. With no dopamine pulse, the simulated striatal radioactivity value at 40 minutes was within 0.5% of the true equilibrium value. Time-activity curves were then simulated with a range of dopamine pulses (pulse height: 333 to 1000 nmollL; clearance rate: 0.025 to 0. 1 min-I ). All of these T AC reached their minimum value at about 70 minutes, and from the minimum had returned less than 20% to the equilibrium value by 90 minutes. This is consistent with not observing an increase in striatal activity toward the end of these studies because of noise. On average, the T AC returned halfway (50%) to the equilibrium value by 110 minutes, with slower clearance rates of dopamine corresponding to longer return times (the magnitude of the dopamine pulse had no effect on return time). A doubling of baseline dopamine postamphetamine, as was typically found in these studies, further delayed the 50% return time to 120 minutes. Thus, if these studies were extended to 120 minutes, the model predicts that the striatal TAC would return partially to the original equi librium level.
CONCLUSION
Recently, there has been great interest in in vivo im aging studies of receptor systems using the competition of radio ligands with endogenous neurotransmitter. How ever, interpretation of these studies is complex because of the combined effects of tracer and neurotransmitter kinetics. Thus, it is helpful in interpreting patient studies to have a model that can predict how various physiologic parameters can affect a given measurement. Here, we have extended the [ l lC]raclopride model to include do pamine competition. The extended model was able to describe the striatal T AC in BII studies with amphet-amine challenge. It also p ermitted a useful inter p retation of changes in s p ecific binding measured with the B/I p rotocol (LlSB). In p articular, the model p redicts that LlSB is p ro p ortional to the integral of the am p hetamine induced do p amine p ulse. Similar modeling studies are required for other neurotransmitter systems to determine if this result is generally a pp licable. Use of these mod eling a pp roaches also can be hel p ful in elucidating in vivo neurotransmitter information (K'fy) and in the selec tion of tracers with the most a pp ro p riate characteristics for these com p etition studies.
